Matthew G. Booty

Matthew G. Booty

Auto-generated profile, based on publicly available information

Matthew G. Booty

Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2007 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
ERElaine F. Remmers
Elaine F. Remmers
RPRobert M. Plenge
Robert M. Plenge
ALAnnette T. Lee
Annette T. Lee
RGRobert R. Graham
Robert R. Graham
GHGeoffrey Hom
Geoffrey Hom
PGPeter K Gregersen
Peter K Gregersen
Rheumatoid arthritis is a chronic inflammatory disease with a substantial genetic component. Susceptibility to disease has been linked with a region on chromosome 2q. We tested single-nucleotide polymorphisms (SNPs) in and around 13 candidate genes within the previously linked chromosome 2q region for association with rheumatoid arthritis. We then performed fine mapping of the STAT1–STAT4 region in a total of 1620 case patients with established rheumatoid arthritis and 2635 controls, all from North America. Implicated SNPs were further tested in an independent case–control series of 1529 patients with early rheumatoid arthritis and 881 controls, all from Sweden, and in a total of 1039 case patients and 1248 controls from three series of patients with systemic lupus erythematosus. A SNP haplotype in the third intron of STAT4 was associated with susceptibility to both rheumatoid arthritis and systemic lupus erythematosus. The minor alleles of the haplotype-defining SNPs were present in 27% of chromosomes of patients with established rheumatoid arthritis, as compared with 22% of those of controls (for the SNP rs7574865, P=2.81×10−7; odds ratio for having the risk allele in chromosomes of patients vs. those of controls, 1.32). The association was replicated in Swedish patients with recent-onset rheumatoid arthritis (P=0.02) and matched controls. The haplotype marked by rs7574865 was strongly associated with lupus, being present on 31% of chromosomes of case patients and 22% of those of controls (P=1.87×10−9; odds ratio for having the risk allele in chromosomes of patients vs. those of controls, 1.55). Homozygosity of the risk allele, as compared with absence of the allele, was associated with a more than doubled risk for lupus and a 60% increased risk for rheumatoid arthritis. A haplotype of STAT4 is associated with increased risk for both rheumatoid arthritis and systemic lupus erythematosus, suggesting a shared pathway for these illnesses.

4 June 2009 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
IAIvona Aksentijevich
Ivona Aksentijevich
SMSeth L. Masters
Seth L. Masters
PFPolly J. Ferguson
Polly J. Ferguson
PDPaul Dancey
Paul Dancey
JFJoost Frenkel
Joost Frenkel
RGRaphaela Goldbach-Mansky
Raphaela Goldbach-Mansky
Autoinflammatory diseases manifest inflammation without evidence of infection, high-titer autoantibodies, or autoreactive T cells. We report a disorder caused by mutations of IL1RN, which encodes the interleukin-1–receptor antagonist, with prominent involvement of skin and bone. We studied nine children from six families who had neonatal onset of sterile multifocal osteomyelitis, periostitis, and pustulosis. Response to empirical treatment with the recombinant interleukin-1–receptor antagonist anakinra in the first patient prompted us to test for the presence of mutations and changes in proteins and their function in interleukin-1–pathway genes including IL1RN. We identified homozygous mutations of IL1RN in nine affected children, from one family from Newfoundland, Canada, three families from the Netherlands, and one consanguineous family from Lebanon. A nonconsanguineous patient from Puerto Rico was homozygous for a genomic deletion that includes IL1RN and five other interleukin-1–family members. At least three of the mutations are founder mutations; heterozygous carriers were asymptomatic, with no cytokine abnormalities in vitro. The IL1RN mutations resulted in a truncated protein that is not secreted, thereby rendering cells hyperresponsive to interleukin-1β stimulation. Patients treated with anakinra responded rapidly. We propose the term deficiency of the interleukin-1–receptor antagonist, or DIRA, to denote this autosomal recessive autoinflammatory disease caused by mutations affecting IL1RN. The absence of interleukin-1–receptor antagonist allows unopposed action of interleukin-1, resulting in life-threatening systemic inflammation with skin and bone involvement. (ClinicalTrials.gov number, NCT00059748.)

9 February 2011 in Mucosal Immunology
Verified
Journal Article
Open access
PDF file
SBS M Behar
S M Behar
CMC J Martin
C J Martin
MBM G Booty
M G Booty
TNT Nishimura
T Nishimura
XZX Zhao
X Zhao
HRH G Remold
H G Remold
Two different forms of death are commonly observed when Mycobacterium tuberculosis (Mtb)-infected macrophages die: (i) necrosis, a death modality defined by cell lysis and (ii) apoptosis, a form of death that maintains an intact plasma membrane. Necrosis is a mechanism used by bacteria to exit the macrophage, evade host defenses, and spread. In contrast, apoptosis of infected macrophages is associated with diminished pathogen viability. Apoptosis occurs when tumor necrosis factor activates the extrinsic death domain pathway, leading to caspase-8 activation. In addition, mitochondrial outer membrane permeabilization leading to activation of the intrinsic apoptotic pathway is required. Both pathways lead to caspase-3 activation, which results in apoptosis. We have recently demonstrated that during mycobacterial infection, cell death is regulated by the eicosanoids, prostaglandin E2 (proapoptotic) and lipoxin (LX)A4 (pronecrotic). Although PGE2 protects against necrosis, virulent Mtb induces LXA4 and inhibits PGE2 production. Under such conditions, mitochondrial inner membrane damage leads to macrophage necrosis. Thus, virulent Mtb subverts eicosanoid regulation of cell death to foil innate defense mechanisms of the macrophage.

4 April 2016 in Nature Medicine
Verified
Journal Article
Open access
PDF file
MMMohlopheni J Marakalala
Mohlopheni J Marakalala
RRRavikiran M Raju
Ravikiran M Raju
KSKirti Sharma
Kirti Sharma
YZYanjia J Zhang
Yanjia J Zhang
EEEliseo A Eugenin
Eliseo A Eugenin
EREric J Rubin
Eric J Rubin
Using proteomic analyses, Eric Rubin, Véronique Dartois and colleagues show that tuberculosis granulomas have spatially segregated protein compositions that compartmentalize pro- and anti-inflammatory responses to distinct regions. Granulomas are the pathological hallmark of tuberculosis (TB). However, their function and mechanisms of formation remain poorly understood. To understand the role of granulomas in TB, we analyzed the proteomes of granulomas from subjects with tuberculosis in an unbiased manner. Using laser-capture microdissection, mass spectrometry and confocal microscopy, we generated detailed molecular maps of human granulomas. We found that the centers of granulomas have a pro-inflammatory environment that is characterized by the presence of antimicrobial peptides, reactive oxygen species and pro-inflammatory eicosanoids. Conversely, the tissue surrounding the caseum has a comparatively anti-inflammatory signature. These findings are consistent across a set of six human subjects and in rabbits. Although the balance between systemic pro- and anti-inflammatory signals is crucial to TB disease outcome, here we find that these signals are physically segregated within each granuloma. From the protein and lipid snapshots of human and rabbit lesions analyzed here, we hypothesize that the pathologic response to TB is shaped by the precise anatomical localization of these inflammatory pathways during the development of the granuloma.

1 September 2012 in Cell Host & Microbe
Verified
Journal Article
Closed access
CMConstance J. Martin
Constance J. Martin
MBMatthew G. Booty
Matthew G. Booty
TRTracy R. Rosebrock
Tracy R. Rosebrock
CNCláudio Nunes-Alves
Cláudio Nunes-Alves
DDDanielle M. Desjardins
Danielle M. Desjardins
SBSamuel M. Behar
Samuel M. Behar

3 March 2014 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
CNCláudio Nunes-Alves
Cláudio Nunes-Alves
MBMatthew G. Booty
Matthew G. Booty
SCStephen M. Carpenter
Stephen M. Carpenter
PJPushpa Jayaraman
Pushpa Jayaraman
ARAlissa C. Rothchild
Alissa C. Rothchild
SBSamuel M. Behar
Samuel M. Behar